Marc Sakwa, MD

Quick facts

Phase 3 pipeline

• Custodiol HTK · Transplantation
  Custodiol HTK is an organ preservation solution that maintains cellular viability and reduces ischemic injury during organ transplantation by providing a balanced electrolyte composition and metabolic substrates.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Marc Sakwa, MD portfolio CI brief
• Marc Sakwa, MD pipeline updates RSS